Cardiff, CA, United States of America

Kyle P Chiang

This inventor holds 68 USPTO granted patents and 18 published patent applications, plus 22 CIPO patents and 26 EPO patents, primarily in Aminoacyl tRNA Synthetases (CPC class C12N). Top assignees: Atyr Pharma, Inc., Pangu Biopharma Limited, Atye Pharma, Inc.. Active years: 2014-2025.

USPTO Granted Patents = 68 

% Patents Active = 91.2

 

 

Average Co-Inventor Count = 7.9

ph-index = 10

Forward Citations = 377(Granted Patents)

Forward Citations (Not Self Cited) = 273(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • San Diego, CA (US) (2015 - 2017)
  • Cardiff, CA (US) (2014 - 2021)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aminoacyl tRNA Synthetases
Histidyl-tRNA
Cysteinyl-tRNA
Therapeutic Conjugates
Inflammation Modulation
Diagnostic Compositions
Protein Fragments
Leucyl-tRNA
Valyl-tRNA
Phenylalanyl-tRNA
Threonyl-tRNA
Tryptophanyl-tRNA
68 patents (USPTO):Explore Patents

Title: Unveiling the Pioneering Work of Inventor Kyle P. Chiang from Cardiff, CA

Introduction:

In the realm of life-changing innovations, Kyle P. Chiang has emerged as a prominent figure, with a staggering 67 patents to her credit. Hailing from Cardiff, CA, Chiang has propelled the field of molecular biology and diagnostics with her groundbreaking discoveries.

Latest Patents:

Among her latest patents is the creation of Histidyl-tRNA synthetase-Fc conjugates, a revolutionary development that offers enhanced properties for treating a myriad of conditions. Moreover, her innovative work on protein fragments of Cysteinyl-tRNA synthetase has opened new avenues in diagnostic, drug discovery, and therapeutic applications.

Career Highlights:

Kyle P. Chiang has left an indelible mark on renowned companies such as aTyr Pharma, Inc. and Pangu Biopharma Limited, where her expertise and ingenuity have fostered new frontiers in biopharmaceuticals. Her relentless pursuit of excellence has set new standards in the industry, inspiring peers and newcomers alike.

Collaborations:

In her endeavors, Chiang has collaborated closely with distinguished professionals such as Jeffry Dean Watkins and John D. Mendlein. These collaborations have not only enriched her work but have also catalyzed innovative solutions to complex challenges in the field.

Conclusion:

In conclusion, Kyle P. Chiang stands as a visionary inventor whose relentless quest for innovation continues to reshape the landscape of molecular biology and biopharmaceuticals. Her prolific career, marked by numerous patents and collaborative successes, serves as a testament to her unwavering commitment to advancing science for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…